Liposomal Vitamin C 1000mg | Phospholipid-Encapsulated for Collagen, Skin & Immune Support

1000 mg of Liposomal Vitamin C per serving — phospholipid-encapsulated to bypass the gut absorption ceiling that caps standard ascorbic acid. The form of Vitamin C that actually reaches plasma at meaningful levels, instead of being excreted in the bathroom an hour later. Third-party tested. Vegetarian capsule, no proprietary blends.

The 30-second answer

• Why this matters at all: Levine 1996 (PNAS) and Levine 2001 (Annu Rev Nutr) showed that the human gut absorbs Vitamin C through saturable sodium-dependent transporters (SVCT1/SVCT2), and that bioavailability of standard ascorbic acid drops sharply above ~200 mg per dose — by 1000 mg in a single dose, less than 50% is absorbed, and at 1250 mg less than 33%. Padayatty 2004 (Annals of Internal Medicine) showed oral ascorbate plasma plateaus around 70–80 µmol/L no matter how much more you take. Liposomal encapsulation routes around that transporter ceiling.
• Why it shows up in every longevity stack: Vitamin C is the obligate cofactor for prolyl-4-hydroxylase and lysyl hydroxylase — the two enzymes that hydroxylate proline and lysine on procollagen so the triple helix can stabilize and cross-link (Myllyharju 2003, Matrix Biology). Without Vitamin C, the collagen you eat or supplement can't be properly assembled. Scurvy is, mechanically, a collagen-synthesis failure.
• What 1000 mg liposomal actually delivers: Davis 2016 (Nutrition and Metabolic Insights) measured plasma ascorbate AUC almost double standard ascorbic acid at the same oral dose; Hickey 2008 (J Nutr Environ Med) earlier reported peak plasma values of ~400 µmol/L from 36g liposomal — far above the standard oral ceiling. The lipid bilayer protects ascorbate from gastric degradation and routes it through lipid-pathway absorption.
• Best for: anyone running a collagen protocol (mandatory cofactor pairing), daily antioxidant baseline, immune resilience during travel/training/post-illness windows, smokers and drinkers (both deplete ascorbate), and as the antioxidant-recycling layer underneath Glutathione, Vitamin E, Resveratrol, and the NAD+ stack.
• Take 1–2 capsules daily with food. Split AM/PM if running 2 capsules — water-soluble vitamins clear the bloodstream within hours, so spaced dosing maintains higher steady-state plasma than a single bolus.

The Pauling controversy and what 50 years of follow-up actually showed

The reason Vitamin C carries more cultural baggage than any other supplement is that it sits at the center of a 50-year argument about dose. The story is worth knowing because the dose conclusions you find on the internet still echo it.

In 1970, Linus Pauling — two-time Nobel laureate (Chemistry 1954, Peace 1962) — published Vitamin C and the Common Cold and proposed that mammals other than humans, primates, and guinea pigs synthesize ascorbate at internal rates equivalent to several grams per day in a human-sized animal, and therefore the human RDA of 60–90 mg/day reflects scurvy-prevention math, not optimal-function math. In 1976 and 1978 he published the Cameron-Pauling clinical observations on terminal cancer patients and high-dose ascorbate (Cameron & Pauling 1976, PNAS; Cameron & Pauling 1978, PNAS), reporting survival benefits.

The Mayo Clinic ran two RCTs (Creagan 1979, NEJM; Moertel 1985, NEJM) that failed to replicate the Cameron-Pauling result and the consensus consolidated against high-dose ascorbate. That's where the story sat for 25 years.

Then Padayatty 2004 (Annals of Internal Medicine) and Padayatty 2010 (PLoS One) reopened it on a single technical point: the Mayo trials used oral dosing while Cameron-Pauling used intravenous. With the SVCT-saturation pharmacokinetics now characterized (Levine 1996 PNAS, Levine 2001 Annu Rev Nutr), it became clear oral and IV ascorbate are not the same molecule pharmacologically — IV reaches plasma 70-100x what oral can produce, and the two routes hit completely different concentration ranges. The Mayo trials had compared a different drug to what Pauling had been studying.

What the modern view actually says — and what the catalog architecture here is built on — is the dose-curve middle ground:

• Pauling was right that the RDA is a scurvy-prevention number, not an optimal-function number. Carr & Frei 1999 (Am J Clin Nutr) and Frei 2012 (Crit Rev Food Sci Nutr) re-derived an "optimal" intake around 200 mg/day from biomarker saturation, neutrophil ascorbate content, and tissue-pool kinetics — about 2–3x the RDA.
• Oral megadose past ~2 g/day adds little plasma ascorbate because the SVCT transporters are saturated. That part of Pauling's protocol — taking 10+ g/day orally — was pharmacokinetically futile.
• IV ascorbate is a different drug entirely and is the appropriate vehicle for any pharmacological-dose research; it's not interchangeable with oral.
• Liposomal encapsulation — the form in this bottle — partially routes around the SVCT ceiling via lipid-pathway absorption (Davis 2016, Hickey 2008), letting an oral dose deliver meaningfully more ascorbate to plasma than the same milligram amount of standard ascorbic acid. It does not match IV. It does close part of the gap.

The honest framing on this product: 1000 mg liposomal is not a Pauling-style megadose claim and not an IV substitute. It is a high-bioavailability daily delivery vehicle for an ascorbate dose that biomarker studies put in the optimal-function range — built around the actual pharmacokinetics that emerged from the Levine-Padayatty work after the Pauling-Mayo argument was already 25 years old.

Why standard ascorbic acid plateaus — the gut transporter ceiling

Vitamin C absorption isn't passive diffusion. It's gated by two sodium-dependent vitamin C transporters (SVCT1 and SVCT2) embedded in the small intestine epithelium. SVCT1 dominates intestinal uptake; SVCT2 handles cellular uptake throughout the body. Both are saturable proteins with finite throughput. Once they're full, they're full.

The Levine pharmacokinetic studies — done at NIH and considered the foundational human data on ascorbate absorption — measured this directly. Healthy young men on controlled diets received single oral doses ranging from 15 mg to 1250 mg. Bioavailability:

• 30–100 mg: near complete absorption (~100%)
• 200–500 mg: starts dropping, ~75–80%
• 1000 mg: drops to ~50%
• 1250 mg: drops to ~33%
• Anything above that: increasing fraction excreted directly in urine

This is why a 1000 mg standard ascorbic acid capsule doesn't actually deliver 1000 mg worth of plasma rise. Most of what you swallow above the SVCT ceiling either sits in the gut osmotically (causing the loose stool that high-dose ascorbic acid is famous for) or gets excreted unchanged.

Padayatty 2004 (Annals of Internal Medicine) confirmed the plasma ceiling: oral ascorbate plateaus around 70–80 µmol/L regardless of how high you push the oral dose. The only way to get higher plasma ascorbate from oral dosing is to bypass the SVCT pathway entirely — which is what liposomal encapsulation does.

What liposomal does differently

A liposome is a microscopic phospholipid bilayer sphere — the same chemistry that makes up your own cell membranes. Vitamin C sits inside the aqueous core, protected by the lipid shell.

• Bypasses the SVCT ceiling. Liposomes don't compete for SVCT throughput. They're absorbed via lipid-pathway transport — passive diffusion, lipid raft uptake, and direct fusion with intestinal cell membranes. Different pathway, no transporter saturation.
• Protects against gastric degradation. Free ascorbate is partially destabilized by stomach acid and gastrointestinal enzymes. The lipid bilayer shields the cargo until it reaches the absorption sites lower in the GI tract.
• Direct cellular delivery. Once in circulation, the liposome's outer bilayer can fuse with target cell membranes, releasing Vitamin C directly into the cytoplasm — bypassing the SVCT2-gated cellular uptake step too.
• Higher AUC at the same dose. Davis 2016 (Nutrition and Metabolic Insights, randomized crossover) compared 4 g of liposomal vs 4 g of standard ascorbic acid: liposomal produced significantly higher plasma AUC over 6 hours. Hickey 2008 (J Nutr Environ Med) reported peak plasma values from megadose liposomal that exceeded the supposed oral ceiling.

The honest framing: liposomal isn't magic, and it doesn't make 1000 mg perform like an IV infusion (only IV bypasses gut absorption entirely, hitting plasma values around 15,000 µmol/L). What it does is push significantly more of an oral dose into circulation than the same milligram amount of standard ascorbic acid — closing a meaningful chunk of the gap between what the label says and what the bloodstream actually sees.

The clinical-evidence bench — a quick reference table

Below is a non-exhaustive but representative pull of the human-trial and pharmacokinetic literature underneath this product. Mechanism-driven studies and RCTs only — no observational-only or animal-only work in the table.

What Vitamin C does at the cellular level — the four main jobs

1. Collagen synthesis cofactor (the structural job)

This is the role most people miss. Vitamin C isn't just "good for skin" — it's a chemically required cofactor in the enzymatic step that converts proline residues on procollagen into hydroxyproline, and lysine into hydroxylysine. Without those hydroxylations, the procollagen triple helix can't fold stably or cross-link, and you get structurally defective collagen — which is exactly what happens in scurvy.

The two key enzymes — prolyl-4-hydroxylase and lysyl hydroxylase — are iron-dependent dioxygenases. They use Fe²⁺ at the active site, and Vitamin C's job is to keep that iron in the reduced (Fe²⁺) state. After each hydroxylation cycle the iron oxidizes to Fe³⁺ and the enzyme stalls. Vitamin C re-reduces it. No Vitamin C, no enzyme turnover, no functional collagen (Myllyharju 2003, Matrix Biology; Pullar 2017, Nutrients on the role of vitamin C in skin health).

This is why pairing collagen supplementation with Vitamin C isn't a marketing add-on — it's the same chemistry your liver uses every day. Take collagen peptides without adequate Vitamin C and you're delivering substrate to a stalled assembly line.

2. Antioxidant network recycling (the regenerative job)

Most people think of Vitamin C as a one-shot antioxidant — donates an electron, becomes oxidized, that's it. The more important role is regenerating other antioxidants in the network:

• Vitamin E (α-tocopherol): Vitamin E sits in cell membranes neutralizing lipid peroxidation. After it donates an electron it becomes the tocopheroxyl radical. Vitamin C, sitting in the aqueous phase right next to the membrane, donates an electron back and regenerates active α-tocopherol (Packer 1979, Nature; classic ascorbate-tocopherol coupling).
• Glutathione (GSH): oxidized glutathione (GSSG) gets reduced back to GSH partly through the ascorbate-glutathione cycle. Vitamin C and glutathione are mutually regenerating partners, not competitors.
• Polyphenols (resveratrol, quercetin, curcumin): after a polyphenol donates a hydrogen atom to neutralize a free radical, Vitamin C can re-reduce it back to active form, extending the polyphenol's antioxidant lifespan in tissue.

The practical implication: Vitamin C doesn't compete with the rest of your antioxidant stack — it amplifies it. Stacking C with Glutathione, Resveratrol, and CoQ10 gets you more total antioxidant capacity than the sum of the individual products.

3. Immune cell function (the defense job)

White blood cells — especially neutrophils, lymphocytes, and macrophages — actively concentrate Vitamin C at 50–100x plasma levels. They use it during the oxidative burst that kills phagocytosed pathogens, and depletion happens fast: a single round of phagocytic activity can drop intracellular ascorbate by 50%, and infection-driven oxidative stress depletes plasma ascorbate within hours (Carr 2017, Nutrients — comprehensive review of vitamin C and immune function).

This is why "I get sick less when I take Vitamin C" isn't just placebo and isn't quite the mythological "prevents colds" claim either. The Hemilä/Chalker 2013 Cochrane review found regular Vitamin C supplementation didn't prevent colds in the general population, but consistently shortened cold duration (~8% in adults, ~14% in children) and was strongly protective against colds in people under heavy physical stress (marathoners, soldiers, cold-weather workers — ~50% reduction in incidence).

The mechanism: keeping intracellular ascorbate high in immune cells means they sustain their oxidative-burst capacity longer and recover faster between cycles.

4. Direct free-radical neutralization (the cleanup job)

In the aqueous phase — cytoplasm, blood plasma, extracellular fluid — Vitamin C is the body's primary water-soluble antioxidant. It neutralizes superoxide (O₂⁻), hydroxyl radical (·OH), peroxyl radicals, hypochlorite (HOCl), and singlet oxygen. This is the role most consumers know about, but it's actually the smaller share of Vitamin C's biological work compared to collagen synthesis and antioxidant recycling. The cleanup job is real, just one of four.

Why liposomal — vs other "enhanced absorption" forms

The supplement market is full of Vitamin C variants that promise better absorption. Honest comparison:

• Plain ascorbic acid: baseline. Cheap, well-studied, hits the SVCT ceiling at ~500 mg per dose. Best absorption is achieved by splitting into 250–500 mg doses across the day rather than one big dose.
• Buffered ascorbates (calcium ascorbate, sodium ascorbate, magnesium ascorbate): easier on the stomach for people who get GI upset from acidic ascorbic acid. Same SVCT ceiling, same bioavailability per mg of ascorbate.
• Ester-C® (calcium ascorbate threonate): marketing claims of better absorption haven't held up to independent comparison studies. Comparable to standard buffered ascorbate.
• Ascorbyl palmitate: a fat-soluble form that incorporates into cell membranes. Useful for membrane-located antioxidant work, but not a higher-bioavailability ascorbate source.
• Liposomal ascorbate: bypasses the SVCT ceiling via lipid-pathway absorption. Higher AUC at the same milligram dose vs ascorbic acid. The closest oral form gets to IV.
• IV Vitamin C: the only way to actually push plasma into the millimolar range (10,000+ µmol/L). Required for any pharmacological-dose protocol; not realistic as a daily baseline.

For daily supplementation, liposomal is the highest-bioavailability oral form. For anyone running a serious antioxidant or collagen protocol, that bioavailability advantage compounds across months of dosing.

Forms of Vitamin C, side-by-side

The Vitamin C aisle is full of forms with overlapping marketing claims. The honest comparison:

Why 1000 mg specifically — the dose curve

Vitamin C dose-response isn't linear. The curve has four characteristic regions, and the right answer depends entirely on what you're trying to do:

• 30–90 mg/day — the scurvy-prevention floor. The RDA. Sufficient to prevent overt scurvy. Below the optimal-function range identified by biomarker saturation studies (Carr & Frei 1999, Frei 2012).
• 200–500 mg/day — the optimal-function band. Plasma ascorbate saturates around 70–80 µmol/L, neutrophils saturate at higher concentrations, and the dose-response curve flattens for most general antioxidant and immune-function endpoints. This is where most of the "Vitamin C is good for X" literature actually sits.
• 1000–2000 mg/day — the protocol-stack band. Where this product lives. Justified for: anyone running a collagen protocol (the cofactor demand scales with collagen substrate intake), anyone in heavy oxidative-stress cycles (athletes, smokers, post-illness, post-surgery), and anyone running an extended antioxidant/longevity stack where the network-recycling role matters more than a single nutrient saturation point. Past ~2 g/day with standard ascorbic acid the SVCT transporters are saturated and the unabsorbed fraction starts hitting the gut osmotically; liposomal extends the productive ceiling because it's not gated by SVCT.
• 5–10 g/day oral — the megadose territory. Pharmacokinetically futile with standard ascorbic acid (most of it is excreted), GI-limited (loose stool above ~3 g for most people), and provides modest plasma rise even with liposomal. Sometimes used for short-term protocols during active illness; not a maintenance dose.
• 10+ g/day IV — pharmacological territory. Different drug. Different pharmacokinetics. Different research literature. Not relevant to oral supplementation decisions.

1000 mg liposomal sits at the top of the protocol-stack band: enough to push plasma into the upper part of the saturable-oral-range while leaving headroom to add another 1000 mg on a heavy-oxidative-stress day or to pair with an additional standard-ascorbate dose at a meal.

Stack with collagen — the cofactor pairing

If you take a collagen supplement and don't pair it with adequate Vitamin C, you are spending money on substrate that can't be assembled. The standard pairings:

• Marine Collagen Peptides 5000 mg + Liposomal Vitamin C — the canonical "beauty from within" pairing. Type I collagen substrate + the cofactor that hydroxylates the proline and lysine residues so the helix stabilizes.
• Multi Collagen Peptides Powder (5 types, 1 lb) + Liposomal Vitamin C — broader collagen-type coverage (I, II, III, V, X) for skin, joints, gut, and bone, same cofactor logic.
• Multi Collagen Complex (capsules, 5 types) + Liposomal Vitamin C — capsule format for travel.
• Hyaluronic Acid 200 mg + Vitamin C already includes 100 mg of standard Vitamin C — if you take it twice daily plus 1000 mg liposomal in the morning, you're well-covered.
• Biotin 10,000 mcg + collagen + Liposomal Vitamin C — the full hair/skin/nails triad: biotin for keratin, collagen for the dermal matrix substrate, Vitamin C as the assembly cofactor.

Stack with the antioxidant network

• + Glutathione 500 mg — Vitamin C and glutathione mutually regenerate each other in the ascorbate-glutathione cycle. Stacking gets you more antioxidant capacity than either alone.
• + NAC 600 mg — NAC is the rate-limiting cysteine substrate for glutathione synthesis; Vitamin C extends the active half-life of the glutathione the NAC builds.
• + Glycine 1500 mg — the second amino acid building block of glutathione. NAC + Glycine + Vitamin C is the full GlyNAC + ascorbate-cycle assembly stack.
• + Astaxanthin 12 mg — fat-soluble carotenoid antioxidant that protects cell membranes; Vitamin C handles the aqueous phase, astaxanthin handles the lipid phase.
• + Alpha-Lipoic Acid 600 mg — both fat- and water-soluble; ALA can also regenerate Vitamin C from its oxidized form (dehydroascorbate), creating a multi-step antioxidant recycling network.

Stack with the longevity / NAD+ protocol

• + Resveratrol 600 mg — Vitamin C regenerates oxidized polyphenols, extending Resveratrol's antioxidant activity in tissue.
• + Pure NMN 500 mg or NMN 1000 mg — supports the broader antioxidant network protecting mitochondria from the increased ROS that comes with elevated NAD+ turnover.
• + CoQ10 400 mg — CoQ10 is recycled at the mitochondrial inner membrane partly through ascorbate-dependent reactions.
• + NAD+ 5-in-1 Complete — the 5-in-1 already contains some Vitamin C; adding 1000 mg liposomal pushes total ascorbate into the range that meaningfully supports collagen synthesis and immune function.

Where this sits in the catalog architecture

Liposomal Vitamin C is one of those products that touches almost every layer of the protocol map, which is why it appears in four separate collection routings rather than a single one:

• Collagen synthesis cofactor layer — pairs structurally with Marine Collagen Peptides, Multi Collagen Powder (5 types), Multi Collagen Complex (capsules), and Hyaluronic Acid + Vit C. Without the ascorbate cofactor, prolyl-4-hydroxylase and lysyl hydroxylase stall and procollagen can't be assembled.
• Antioxidant network recycling layer — sits inside the ascorbate-glutathione cycle (Vitamin C ↔ Glutathione ↔ NAC ↔ Glycine) and the ascorbate-tocopherol couple, regenerating Vitamin E in cell membranes after each lipid-peroxidation neutralization (Packer 1979). Pairs with Astaxanthin (lipid phase) and Alpha-Lipoic Acid (both phases).
• Polyphenol-recycling layer — Vitamin C re-reduces oxidized polyphenols, extending the effective half-life of Resveratrol, Quercetin, Curcumin, and Pterostilbene.
• Immune resilience layer — neutrophils, lymphocytes, and macrophages concentrate ascorbate 50–100x plasma (Carr 2017); the depletion-during-oxidative-burst cycle is what the cold-duration meta-analysis (Hemilä/Chalker 2013) tracks at the population level.
• NAD+ stack adjacency — supports the broader antioxidant network protecting mitochondria from elevated ROS that comes with NAD+-driven mitochondrial activity. Cross-links with NMN 500 mg, NMN 1000 mg, CoQ10 400 mg, and the NAD+ 5-in-1 Complete formula (which already contains a partial Vitamin C dose; pairing 1000 mg liposomal pushes total ascorbate into the protocol-stack band).

Collection routing: Antioxidants, Foundational Health, Collagen, Skin Protocol, Beauty & Anti-Aging, Longevity Essentials.

Who this is for

• Anyone taking a collagen supplement (mandatory cofactor pairing — not optional)
• Adults wanting a daily antioxidant baseline that meaningfully raises plasma and tissue Vitamin C
• Frequent travelers, athletes in heavy training, students or workers in immune-stress windows
• Smokers and regular drinkers — both deplete plasma ascorbate substantially (smokers need ~35 mg/day more just to maintain baseline)
• People recovering from illness, surgery, or wounds (Vitamin C demand spikes during repair)
• Anti-aging stacks focused on free-radical defense, skin health, and collagen support

Who this is NOT for (or talk to a clinician first)

• History of calcium oxalate kidney stones. Vitamin C is metabolized partly to oxalate. High doses (typically >1000 mg/day) can modestly raise urinary oxalate excretion. If you've had oxalate stones, talk to your doctor before regular high-dose ascorbate.
• Hemochromatosis or iron overload conditions. Vitamin C dramatically increases non-heme iron absorption. People who can't dispose of excess iron should not take high-dose Vitamin C with iron-containing meals or supplements without medical guidance.
• G6PD deficiency. Very high doses (typically pharmacological IV doses) can trigger hemolysis in G6PD-deficient individuals. Standard oral doses are generally fine, but talk to your doctor.
• Chemotherapy or active cancer treatment. Some chemo regimens may interact with high-dose antioxidants. Coordinate with your oncology team.
• Pregnancy or nursing. Standard dietary intake is essential; megadose supplementation hasn't been thoroughly studied in pregnancy. Talk to your OB.

What to expect — the realistic timeline

• Days 1–7: plasma and tissue ascorbate rise. People who were running deficient (smokers, chronic dieters, post-illness) may notice subtle skin tone or energy changes here.
• Weeks 2–4: if stacking with collagen, the cofactor effect on collagen synthesis compounds — visible skin firmness improvements often track here, matching the Proksch 2014 collagen-trial timelines.
• Weeks 4–8: antioxidant network steady-state; immune resilience improvements (faster recovery from minor illness, less post-workout inflammation) usually show in this window.
• Months 3+: sustained collagen-synthesis support, sustained antioxidant recycling capacity. Continued use is the maintenance dose; if you stop, plasma ascorbate returns to dietary baseline within 1–2 weeks.

Common mistakes to avoid

1. Taking 1000 mg ascorbic acid in a single dose and expecting 1000 mg of plasma rise. Levine 1996 says you'll absorb ~50% of it. Either split the dose or use liposomal.
2. Stacking collagen without the cofactor. Collagen peptides without enough Vitamin C is substrate without an assembly enzyme. The pairing isn't optional — it's the rate-limiting biochemistry.
3. Treating liposomal like IV. Liposomal pushes oral plasma higher; it does not produce IV-range concentrations (15,000+ µmol/L). Different molecule, different research.
4. Megadosing past 3 g/day with standard ascorbic acid. SVCT-saturated, GI-osmotic, and most of it ends up in the urine. If you need more, use liposomal or split across the day; don't try to brute-force the SVCT ceiling.
5. Taking it 24–48 hours before a glucose finger-stick or stool occult-blood test. High-dose Vitamin C interferes with both. Pause if your clinician asks.
6. Pairing with iron when you have hemochromatosis or unexplained ferritin elevation. Vitamin C ~3-4x non-heme iron absorption — helpful for iron-deficiency anemia, dangerous in iron overload.
7. Single morning megabolus instead of split dosing. Vitamin C is water-soluble and clears within hours. For a sustained-plasma protocol, split AM/PM rather than dumping the whole day's dose at breakfast.

Directions

Take 1–2 capsules daily with food. Vitamin C is water-soluble — taking with food is more about absorption tolerance and steady release than a fat-pairing requirement. If running 2 capsules, split them across the day (morning + early afternoon) for sustained plasma levels rather than a single morning bolus. Avoid taking immediately before bed — the small amount of bioactive compound can be mildly stimulating in sensitive individuals.

Pair the morning dose with collagen if you're running a beauty/skin protocol. Pair the second dose with the rest of your antioxidant stack (Glutathione, NAC, Astaxanthin) for the recycling synergy.

Per-capsule ingredient panel

Free of: titanium dioxide, artificial colors, magnesium stearate, GMOs, soy, gluten, dairy, eggs, peanuts, tree nuts, fish, shellfish.

Sourcing, manufacturing, and quality control

• Ascorbate raw material. Pharmaceutical-grade L-ascorbic acid, USP-monograph compliant, sourced from cGMP suppliers. Identity confirmed by FTIR and HPLC; assay ≥99.0% per USP <1215>.
• Liposome shell. Sunflower-derived phosphatidylcholine (no soy lecithin). Sized phospholipid bilayer vesicles produced by high-shear / ultrasonic processing — not the loose lecithin-and-ascorbate powder mixes that some "liposomal" products on the market actually are.
• Manufacturing. cGMP per 21 CFR Part 111. ISO 9001 certified facility, FDA-registered. Per-batch documentation retained for a minimum of 24 months past expiration.
• Per-batch testing. HPLC ascorbate assay (label-claim verification), USP <2232> heavy metals (Pb, Cd, As, Hg under proposition-65 thresholds), USP <2021> / <2022> microbial limits (TAMC, TYMC, absence of E. coli / Salmonella / S. aureus), USP <467> residual solvents, and USP <561> pesticide screen on the phospholipid raw material.
• Stability. 24-month shelf life from manufacture date. Stored in UV-protective amber HDPE bottles with desiccant; ascorbate is photo- and oxidation-sensitive, and the bottle format is part of the protection plan.
• Documentation. Certificate of Analysis available on request via support@truehealthprotocol.health. Batch-level traceability from raw material lot through finished-good lot.

Safety notes

• GI tolerance: the liposomal form is dramatically gentler on the stomach than equivalent ascorbic acid doses (no osmotic-load loose stool from unabsorbed ascorbate). Most people tolerate 1–2 capsules with no GI effect.
• Iron interaction: Vitamin C increases non-heme iron absorption ~3-4x. Helpful for iron-deficient individuals, problematic for hemochromatosis. If you're on iron supplementation, taking C with the iron is intentional. If you're avoiding iron uptake, separate by a few hours.
• Lab interference: high-dose Vitamin C can interfere with some glucose meter readings (false low) and stool occult-blood tests (false negative). Pause for 24–48 hours before relevant lab tests if your clinician asks.
• Drug interactions: may modestly enhance estrogen absorption from oral contraceptives; may increase aluminum absorption from aluminum-containing antacids. Generally well-tolerated with most medications.
• Surgery: no specific Vitamin C washout is typically required, but disclose all supplements to your surgical team.

FAQ

Q: Is liposomal really worth the price difference vs standard Vitamin C?
A: For people taking C purely for general antioxidant intake at modest doses (~250–500 mg daily), standard ascorbic acid split into 2 doses is fine and cheaper. For people running a 1000+ mg daily protocol — for collagen synthesis, antioxidant network support, immune resilience, or longevity stacking — liposomal closes a real bioavailability gap that standard ascorbic acid can't match without going to IV.

Q: Will I get loose stool from this like high-dose ascorbic acid?
A: Almost certainly not at 1–2 capsules. The osmotic loose stool from high-dose ascorbic acid is caused by unabsorbed ascorbate sitting in the gut. Liposomal absorption bypasses that pathway, so you don't get the unabsorbed-ascorbate osmotic load.

Q: Can I take it with my collagen powder in the morning?
A: Yes, this is the recommended pairing. Take collagen + Vitamin C together in the same window so the ascorbate is at peak plasma exactly when prolyl-4-hydroxylase is processing the procollagen substrate.

Q: Is more better? Should I take 5–10 grams a day?
A: For daily maintenance, no — diminishing returns above ~2 g/day for most people. Megadose protocols (5+ g/day) are sometimes used short-term during active illness but carry GI tolerance issues and modestly increased oxalate excretion. For a daily longevity/beauty/immune baseline, 1–2 capsules (1000–2000 mg liposomal) is the sweet spot.

Q: Does it actually work for skin brightening like the Asian beauty market claims?
A: Vitamin C inhibits tyrosinase (the enzyme that synthesizes melanin), which is the mechanism behind the "brightening" claim. Topical Vitamin C has stronger evidence for spot lightening; oral Vitamin C is more about supporting overall collagen-driven skin firmness and protecting against UV-induced oxidative damage. The two work well together.

Q: How does it compare to IV Vitamin C?
A: IV Vitamin C produces plasma levels around 15,000 µmol/L — pharmacological, not nutritional. Oral liposomal at 1000–2000 mg produces plasma levels several-fold above standard oral ascorbate but still in the nutritional range (typically 200–400 µmol/L peak). Liposomal is for daily nutritional support; IV is for clinical protocols and not interchangeable.

Q: Should I take it with my multivitamin or as separate?
A: Either works. Most multivitamins contain only 60–100 mg Vitamin C, which is below the 1000 mg target dose. Taking the liposomal as a separate dose lets you split the day (morning + afternoon) for sustained plasma rather than getting it all in the multi.

Q: Can I open the capsule and mix into water or smoothies?
A: Yes — the liposomes survive in solution for short periods. Best practice is to mix and consume within a few minutes; long storage in water or acidic drinks (juice, smoothies with citrus) will start to degrade both the ascorbate and the liposome shell.

Q: Is this OK during pregnancy or breastfeeding?
A: Standard dietary Vitamin C is essential during pregnancy. Megadose supplementation hasn't been well-studied in pregnancy, so talk to your OB before starting any 1000+ mg/day protocol while pregnant or nursing.

Q: I take iron supplements — should I take this with or apart from them?
A: With them, intentionally. Vitamin C dramatically improves non-heme iron absorption — this is the standard recommendation for iron-deficiency anemia protocols. Take both at the same meal.

Q: I have a history of kidney stones — can I take this?
A: Calcium oxalate stones (the most common kind) can be modestly aggravated by high-dose Vitamin C in some individuals because ascorbate metabolism produces oxalate. If you have a history of oxalate stones, talk to your doctor before regular 1000+ mg dosing.

Q: Vegan/vegetarian?
A: Yes. Sunflower-derived phospholipids (no soy, no animal-derived lecithin), vegetable cellulose capsule, no animal ingredients.

Why not Amazon

Three differentiators worth knowing before you compare bottles on price alone:

• True liposomal vs lecithin-mixed. A meaningful share of "liposomal Vitamin C" products on marketplace listings are not actually liposomal — they're sunflower lecithin powder mixed with ascorbic acid in a capsule. That mix doesn't form sized bilayer vesicles and doesn't deliver the bioavailability profile Davis 2016 measured. This product uses processed phospholipid bilayer vesicles, not a powder mix.
• Pharmaceutical-grade ascorbate vs commodity. USP-monograph ≥99% L-ascorbic acid with HPLC assay verification per batch. Commodity ascorbate at the lower-priced end of the marketplace doesn't always meet that standard.
• Catalog architecture. The protocol-stack rationale — Vitamin C as collagen cofactor, polyphenol regenerator, GSH-cycle partner, immune-cell concentrate — is built into the cross-linked collection routing. You can stack with Marine Collagen, Multi Collagen Powder, Glutathione, NAC, Glycine, Astaxanthin, ALA, Resveratrol, NMN, CoQ10, NAD+ 5-in-1 from the same catalog with the protocol logic spelled out, rather than guessing at compatibility from product page to product page.

Read more on this topic

• How to choose a collagen supplement (Vitamin C is the cofactor)
• Marine Collagen for Hair Growth — what actually works
• Marine vs bovine collagen — which works faster
• Glutathione for skin brightening — how it works
• Hyaluronic acid for skin — topical vs oral
• Foundational Health: the 7 daily nutrients underneath every longevity stack
• How to stack longevity supplements — practical protocol 2026
• The True Health Protocols (full stacking guide)
• Our Science — the Hallmarks of Aging framework
• Quality & testing standards
• Ingredient sourcing
• Browse the Longevity Essentials collection
• Browse the Beauty & Anti-Aging collection
• Browse the Collagen collection
• Browse the Skin Protocol collection
• Browse the Antioxidants collection

Selected references

1. Pauling L. Vitamin C and the Common Cold. W. H. Freeman, 1970.
2. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1976; 73(10): 3685–9.
3. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1978; 75(9): 4538–42.
4. Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C therapy to benefit patients with advanced cancer. N Engl J Med 1979; 301: 687–690.
5. Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer. N Engl J Med 1985; 312: 137–141.
6. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996; 93(8): 3704–9.
7. Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 2001; 98(17): 9842–6. (And Levine 2001 Annu Rev Nutr review.)
8. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999; 69(6): 1086–107.
9. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004; 140: 533–537.
10. Padayatty SJ, Sun AY, Chen Q, et al. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 2010; 5(7): e11414.
11. Hickey S, Roberts HJ, Miller NJ. Pharmacokinetics of oral vitamin C. J Nutr Environ Med 2008; 17(3): 169–177.
12. Davis JL, Paris HL, Beals JW, et al. Liposomal-encapsulated ascorbic acid: influence on vitamin C bioavailability and capacity to protect against ischemia-reperfusion injury. Nutr Metab Insights 2016; 9: 25–30.
13. Frei B, Birlouez-Aragon I, Lykkesfeldt J. Authors' perspective: what is the optimum intake of vitamin C in humans? Crit Rev Food Sci Nutr 2012; 52(9): 815–29.
14. Lykkesfeldt J, Michels AJ, Frei B. Vitamin C. Adv Nutr / Nutrients reviews 2014.
15. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013; (1): CD000980.
16. Carr AC, Maggini S. Vitamin C and immune function. Nutrients 2017; 9(11): 1211.
17. Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients 2017; 9(8): 866.
18. Myllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biology 2003; 22: 15–24.
19. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278: 737–8.
20. Niki E. Free radicals and antioxidants in clinical biology. Free Radic Biol Med 1995.
21. Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol 2008; 26(2): 106–22.
22. Proksch E, Segger D, Degwert J, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology. Skin Pharmacol Physiol 2014; 27: 47–55.
23. Asher GN, Spelman K. Clinical utility of curcumin extract — illustrative reference for the polyphenol-recycling stacking rationale.

References cited above are summarized for educational context and are not endorsements by the cited authors of this specific product. Doses noted in the studies cited do not necessarily reflect the dose of this product, and Vitamin C is not a treatment for any specific disease. Talk to your physician before starting a 1000+ mg/day Vitamin C protocol if you are pregnant or nursing, have hemochromatosis or a history of calcium oxalate kidney stones, are on chemotherapy, or take iron supplementation regularly. Have a question? Email support@truehealthprotocol.health.